-
熙康云医院公布2025年中期业绩：护理核心业务收入增长超40%，期内经调整净亏损进一步收窄
-
越捷航空推出限时三天“0元机票”闪促活动
-
菜百股份：2025年上半年营收同增38.75%，电商渠道持续发力
-
锚定睡眠赛道，共话品牌韧性：尚驰亮相新华网国民品牌新势力峰会
-
菜百股份：紧抓市场机遇 2025年上半年业绩喜人
-
鑫瑞新材料科技：以超临界发泡技术推动多领域绿色创新与产业升级
-
连送四天！秋林里道斯红肠马博会免费领
-
金矢留学对话埃塞克斯大学：区位优越，教研双优，入学支持本土化
-
Countdown For A Cure Awards $350,000 Grant to Minovia Therapeutics to Advance Groundbreaking Mitochondrial Biomarker Research
-
VCI Global Partners with Reveillon Group to Launch Global RWA Lounge Network and Creator Monetization Platform
-
精品短剧《奔腾的心》正式开机，以匠心描绘新时代西藏故事
-
The Recruiter is Back: Modelo Launches Largest-Ever Push to Reward Full Time College Football Fans
-
Wood Mackenzie launches Nodal Price Forecast
-
Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound
-
Obstructive Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
-
金融科技巨头ATRNX获Luminga Capital 3000万美元战略投资
-
逆水寒账号交易新选择：牛号邦打造安全高效交易环境
-
Acronis and Intel Partner to Deliver Efficient, AI-Driven Threat Detection for Endpoint Devices
-
nCino to Participate in Upcoming Investor Events
-
Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers
三星官宣5月13日举行新品发布会，超轻薄Galaxy S25 Edge发布
广东省药监局调研恒昌医药集团，聚焦药品流通产业高质量发展